| HBV patients |  | HCV patients | ||||
---|---|---|---|---|---|---|---|
Variables | All | Initial exposure | Initial non-exposure | Â | All | Initial exposure | Initial non-exposure |
n | 7724 | 3575 | 4149 | Â | 7873 | 3349 | 4524 |
Gender (male, %) | 66.2 | 68.8* | 63.9 | Â | 49.3 | 51.8* | 47.4 |
Mean age (years) (SD) | 57.4 (11.3) | 57.5 (11.2) | 57.3 (11.5) | Â | 59.5 (9.1) | 59.7 (9.3) | 59.3 (9.0) |
Liver cirrhosis (%) | 78.9 | 77.8* | 79.8 | Â | 88.0 | 87.0* | 88.7 |
Comorbidities | Â | Â | Â | Â | Â | Â | Â |
 DM (%) | 36.6 | 43.8* | 30.4 |  | 35.9 | 45.7* | 28.6 |
 Hyperlipidemia (%) | 40.3 | 45.6* | 35.7 |  | 31.3 | 36.4* | 27.6 |
 Other cancer (%) | 24.8 | 21.1* | 27.7 |  | 4.6 | 4.2 | 5.0 |
 COPD (%) | 11.4 | 11.3 | 11.5 |  | 12.0 | 12.5 | 11.7 |
 End-stage renal disease (%) | 1.7 | 1.7 | 1.6 |  | 1.2 | 1.3 | 1.2 |
 Transplant (%) | 2.9 | 3.1 | 2.7 |  | 0.6 | 0.9* | 0.3 |
 Alcohol use (%) | 1.7 | 1.2* | 2.2 |  | 0.7 | 0.4* | 0.9 |
Mean follow up years (SD) | 4.0 (1.7) | 4.0 (1.6) | 4.0 (1.7) | Â | 4.6 (1.5) | 4.5 (1.4) | 4.7 (1.5) |
Last status | Â | Â | Â | Â | Â | Â | Â |
 HCC (n, %) | 552 (7.1) | 258 (7.2) | 294 (7.1) |  | 503 (6.4) | 193 (5.8) | 310 (6.9) |
 Death (n, %) | 1282 (16.6) | 508 (14.2) | 774 (18.7) |  | 261 (3.3) | 115 (3.4) | 146 (3.2) |